Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.

Matthäus MajewskiPia PaffenholzChristian RufYue CheChristoph SeidelJulia HeinzelbeckerHans-Ulrich SchmelzCord MatthiesPeter AlbersCarsten BokemeyerAxel HeidenreichMartin Pichler Tim Nestlernull null

Published in: Cancer medicine (2023)

The use of pre-orchiectomy tumor marker levels may lead to an incorrect risk classification and might subsequently lead to under- or overtreatment of patients.

Keyphrases

germ cell
machine learning
end stage renal disease
deep learning
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
combination therapy
replacement therapy